Which New Skin Lasers Actually Work, and Which Are Just Marketing?

Walk into any med spa in 2026 and you will hear a wall of proper nouns deployed with total confidence: Moxi, Clear + Brilliant, Halo, UltraClear, picosecond, RF microneedling. The words alone are supposed to signal expertise. They do not explain what is actually happening to your face. Here is what the physics, the published studies, and the dermatologists on record are actually saying, separated from what the consultation-room script wants you to believe.

The naming problem is the marketing problem

"Fractional" simply means a device fires energy in a grid of microscopic columns instead of covering the whole surface, leaving untouched skin between treated zones so healing happens faster. That is the entire definition. It is not a brand, not a luxury tier, not a guarantee of results. Clear + Brilliant has been marketed for over a decade as "Baby Fraxel," a nickname invented in treatment rooms, not a clinical classification, and it sits in the same functional category as Moxi, Sciton's 1927 nm nonablative fractional device: energy mild enough to carry close to zero real downtime, aimed at early photodamage, faint texture, and maintenance, not at deep wrinkles, acne scarring, or lax skin. Patients who need heavier correction get steered toward Halo, a hybrid platform blending ablative and nonablative wavelengths in one pass, traditional fractional CO2 or Er:YAG resurfacing, or a Fraxel Dual treatment dialed to higher energy. Same manufacturer family in some cases, an entirely different clinical job.

The point dermatologists keep making, and marketing keeps burying, is that outcomes depend on settings, technique, and the person holding the handpiece, not the platform's name recognition. A Clear + Brilliant session run at low energy by an inexperienced provider will do less for your skin than a well-executed IPL treatment. The device name is not the variable that matters most.

What is actually new this year

Two things circulating in 2026 aesthetic dermatology are worth knowing by name because they represent real engineering or clinical-protocol changes, not rebrands with new marketing decks.

• UltraClear is a cleared 2910 nm erbium-doped fiber laser for controlled tissue ablation, coagulation, and resurfacing. “Cold ablative” is marketing shorthand, not an absence of thermal injury; the device still ablates tissue and can produce erythema, edema, crusting, and pigment change. Published evidence remains relatively small: in one prospective study, 22 participants enrolled and 15 completed three treatments, with two temporary hyperpigmentation events reported. Larger, diverse, independently replicated comparisons are still needed.¹²
• A prospective study evaluated a paired radiofrequency-microneedling and 755 nm picosecond-laser protocol. Because both procedures were delivered together and only 18 of 25 participants completed three-month follow-up, the results cannot establish which component produced the benefit or how the combination compares with either treatment alone. Treating-physician improvement and 88.9-percent satisfaction were reported among the small group completing follow-up; these global ratings do not prove that every patient improves or that the protocol is superior to alternatives.³

Skin tone is not a footnote, it is the deciding variable

Radiofrequency microneedling delivers energy below the skin surface, but it can still cause post-inflammatory hyperpigmentation, burns, scarring, infection, and fat injury. Risk in darker skin depends on device, needle depth, energy, technique, aftercare, and operator experience. The industry line that it carries meaningfully lower pigment risk than laser resurfacing has not been established by any trial that isolates it from the treatments it is usually paired with.³⁴

The right choice depends on your unique skin profile, your concerns, and your recovery tolerance, not on which platform has the better name.

The risks nobody writes on the consultation-room whiteboard

Prices vary by location, treatment area, anesthesia, operator, and number of sessions, and no representative national dataset exists for what any of these treatments actually cost; which is worth knowing before a price list is presented to you as a standard rate. A board-certified dermatologist should assess diagnosis, skin type, medication history, pigment risk, device clearance, and realistic downtime before treatment.¹²³⁴

None of this is a reason to avoid these devices. The clinical evidence behind fractional resurfacing, RF microneedling, and picosecond lasers is real and still growing. It is a reason to get your consultation from a board-certified dermatologist or a physician-supervised practice rather than a med spa price list, before anyone points a handpiece at your face. Ask what wavelength, what energy setting, and why for your skin specifically, not why for the device's marketing copy.